VXRT vs WBA
Vaxart Inc (VXRT) versus WBA (WBA) — a side-by-side from cached financials, not a winner call.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
WBA (WBA) common stock.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
WBA does not have a complete income-statement cache yet.
VXRT currently screens at market cap $73.0M.
Not investment advice. Open the VXRT and WBA stock pages for the full models.
Not investment advice.